✦ LIBER ✦

148. A randomized controlled trial of enzyme replacement therapy in Fabry disease: The Canadian Fabry disease initiative at year three

✍ Scribed by Michael West; Kaye LeMoine; Daniel Bichet; Joe Clarke; Robin Casey; Sandra Sirrs; Christiane Auray-Blais; David Sinasac; Gordon Flowerdew

Book ID: 116988885
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 42 KB
Volume: 99
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2009.10.165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Results of Switching Enzyme

Prospective Results of Switching Enzyme Replacement Therapy from Agalsidase beta to Agalsidase alfa in the Canadian Fabry Disease Initiative Study

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Gordon Flowe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P10—Comprehensive Assessment of Long-Ter

P10—Comprehensive Assessment of Long-Term Enzyme Replacement Therapy in Fabry Disease: The 5-Year Data

✍ E.K. Baumgärtner; M. Niemann; A. Emmert; F. Breunig; J. Strotmann; M. Beer; C. S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A randomized, open-label study to compar

A randomized, open-label study to compare the efficacy and safety of AT1001 and enzyme replacement therapy (ERT) in patients with Fabry disease and AT1001-responsive GLA mutations, who were previously treated with ERT

✍ Mathews Adera; Allison Gladden; Pol Boudes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

148.&#xa0;A randomized controlled trial of enzyme replacement therapy in Fabry disease: The Canadian Fabry disease initiative at year three

148. A randomized controlled trial of enzyme replacement therapy in Fabry disease: The Canadian Fabry disease initiative at year three